ruthenium has been researched along with oxyquinoline in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 5 (41.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, X; Wang, H; Wang, J; Yang, L; Zhao, Y | 1 |
| Liu, J; Qin, X; Wang, C; Yang, L; Yu, Q; Zhang, J; Zhou, Y | 1 |
| Gobec, M; Gobec, S; Kljun, J; Mlinarič-Raščan, I; Sosič, I; Turel, I; Uršič, M | 1 |
| De, S; Jacob, R; Maiti, S; Mondal, A; Moorthy, A; Paira, P; Sarkar, B; Sk, AK | 1 |
| Hanif, M; Hartinger, CG; Holtkamp, HU; Jamieson, SMF; Movassaghi, S; Söhnel, T | 1 |
| Bai, Y; Cadavid-Vargas, JF; Etcheverry, SB; He, W; Kljun, J; León, IE; Peršič, Š; Turel, I | 1 |
| Di Virgilio, AL; Kljun, J; León, IE; Ruiz, MC; Turel, I | 1 |
| Peng, YB; Tan, CP; Tao, C; Zhao, P | 1 |
| Csuvik, O; Dömötör, O; Enyedy, ÉA; May, NV; Mészáros, JP; Pivarcsik, T; Spengler, G; Szatmári, I | 1 |
| Das, U; P K, A; Paira, P; Roy, N; Sahoo, SK; Varddhan, S | 1 |
| Huang, B; Li, R; Lu, J; Ma, X; Yang, P; Ye, R; Zhang, Z | 1 |
| Chen, J; Chen, X; Gong, Y; Huang, M; Huang, Z; Liang, Z; Ni, Y; Pan, X; Sun, J; Wu, W; Zhang, Y | 1 |
12 other study(ies) available for ruthenium and oxyquinoline
| Article | Year |
|---|---|
Structural, electronic, vibrational and NMR spectral analyses of [Ru(OAc)(2cqn)2NO] (H2cqn=2-chloro-8-quinolinol) isomers.
Topics: Coordination Complexes; Isomerism; Magnetic Resonance Spectroscopy; Models, Molecular; Nitrogen Oxides; Oxyquinoline; Quantum Theory; Ruthenium; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared | 2014 |
Interaction between 8-hydroxyquinoline ruthenium(II) complexes and basic fibroblast growth factors (bFGF): inhibiting angiogenesis and tumor growth through ERK and AKT signaling pathways.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Movement; Cell Proliferation; Coordination Complexes; Fibroblast Growth Factor 2; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Male; MAP Kinase Signaling System; Mice; Mice, SCID; Neoplasms; Oxyquinoline; Proto-Oncogene Proteins c-akt; Ruthenium; Signal Transduction | 2014 |
Structural characterization and biological evaluation of a clioquinol-ruthenium complex with copper-independent antileukaemic activity.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Clioquinol; Copper; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Jurkat Cells; Leukemia; MCF-7 Cells; NF-kappa B; Oxyquinoline; Proteasome Endopeptidase Complex; Ruthenium | 2014 |
Amberlite IR-120 (H) mediated "on water" synthesis of fluorescent Ruthenium(II)-arene 8-hydroxyquinoline complexes for cancer therapy and live cell imaging.
Topics: Antineoplastic Agents; Binding Sites; Caco-2 Cells; Cell Line, Tumor; Cell Survival; Coordination Complexes; DNA; HeLa Cells; Humans; Inhibitory Concentration 50; MCF-7 Cells; Neoplasms; Oxyquinoline; Polystyrenes; Protein Binding; Ruthenium; Serum Albumin, Bovine; Structure-Activity Relationship; Water | 2018 |
Making organoruthenium complexes of 8-hydroxyquinolines more hydrophilic: impact of a novel l-phenylalanine-derived arene ligand on the biological activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Stability; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Molecular Conformation; Oxyquinoline; Phenylalanine; Ruthenium | 2018 |
Synthesis and biological characterization of organoruthenium complexes with 8-hydroxyquinolines.
Topics: A549 Cells; Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Humans; Neoplasms; Organometallic Compounds; Oxyquinoline; Ruthenium | 2018 |
Comparative antitumor studies of organoruthenium complexes with 8-hydroxyquinolines on 2D and 3D cell models of bone, lung and breast cancer.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Humans; Models, Biological; Neoplasms; Organometallic Compounds; Oxyquinoline; Ruthenium; Ruthenium Compounds | 2019 |
Inhibition of Aβ peptide aggregation by ruthenium(II) polypyridyl complexes through copper chelation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Benzimidazoles; Cell Line, Tumor; Cell Survival; Chelating Agents; Coordination Complexes; Copper; Humans; Mitochondria; Neurons; Oxyquinoline; Protein Aggregates; Protein Aggregation, Pathological; Reactive Oxygen Species; Ruthenium | 2021 |
8-Hydroxyquinoline-Amino Acid Hybrids and Their Half-Sandwich Rh and Ru Complexes: Synthesis, Anticancer Activities, Solution Chemistry and Interaction with Biomolecules.
Topics: Amino Acids; Antineoplastic Agents; Apoptosis; Cell Proliferation; Colonic Neoplasms; Coordination Complexes; Humans; Oxyquinoline; Rhodium; Ruthenium; Tumor Cells, Cultured | 2021 |
[Ru(η
Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Carcinoma; Cell Line, Tumor; Chemistry, Pharmaceutical; Coordination Complexes; Cymenes; Humans; Oxyquinoline; Ruthenium; Tissue Distribution; Zebrafish | 2022 |
8-Hydroxyquinoline-modified ruthenium(II) polypyridyl complexes for JMJD inhibition and photodynamic antitumor therapy.
Topics: 2,2'-Dipyridyl; Antineoplastic Agents; Apoptosis; Caspases; Coordination Complexes; Histones; Humans; Ligands; Oxyquinoline; Reactive Oxygen Species; Ruthenium | 2022 |
8-Hydroxyquinoline ruthenium(II) complexes induce ferroptosis in HeLa cells by down-regulating GPX4 and ferritin.
Topics: Animals; Ferritins; Ferroptosis; HeLa Cells; Humans; Oxyquinoline; Ruthenium; Zebrafish | 2023 |